Detalles de la búsqueda
1.
Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantation.
Br J Haematol
; 195(5): 757-763, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34581433
2.
Early antimicrobial prophylaxis in autologous stem cell transplant recipients: Conventional versus an absolute neutrophil count-driven approach.
Transpl Infect Dis
; 23(4): e13689, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34255395
3.
Allogeneic Hematopoietic Cell Transplant for HIV Patients with Hematologic Malignancies: The BMT CTN-0903/AMC-080 Trial.
Biol Blood Marrow Transplant
; 25(11): 2160-2166, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31279752
4.
Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study.
Biol Blood Marrow Transplant
; 25(4): 699-711, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30423480
5.
Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors.
Haematologica
; 104(4): 844-854, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30381298
6.
Survival outcomes of allogeneic hematopoietic cell transplants with EBV-positive or EBV-negative post-transplant lymphoproliferative disorder, A CIBMTR study.
Transpl Infect Dis
; 21(5): e13145, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31301099
7.
Effect of Antihuman T Lymphocyte Globulin on Immune Recovery after Myeloablative Allogeneic Stem Cell Transplantation with Matched Unrelated Donors: Analysis of Immune Reconstitution in a Double-Blind Randomized Controlled Trial.
Biol Blood Marrow Transplant
; 24(11): 2216-2223, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30006305
8.
ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors.
Biol Blood Marrow Transplant
; 24(6): 1119-1124, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29608957
9.
Outcomes of allogeneic haematopoietic cell transplantation for chronic neutrophilic leukaemia: A combined CIBMTR/CMWP of EBMT analysis.
Br J Haematol
; 198(4): 785-789, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35658101
10.
Personalizing Busulfan-Based Conditioning: Considerations from the American Society for Blood and Marrow Transplantation Practice Guidelines Committee.
Biol Blood Marrow Transplant
; 22(11): 1915-1925, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27481448
11.
Tbo-Filgrastim versus Filgrastim during Mobilization and Neutrophil Engraftment for Autologous Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 21(11): 1921-5, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26033279
12.
Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Guidelines from the American Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 21(7): 1155-66, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25769794
13.
Conditioning chemotherapy dose adjustment in obese patients: a review and position statement by the American Society for Blood and Marrow Transplantation practice guideline committee.
Biol Blood Marrow Transplant
; 20(5): 600-16, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24462742
14.
Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations.
Biol Blood Marrow Transplant
; 20(3): 295-308, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24141007
15.
Safety and efficacy of targeted-dose busulfan and bortezomib as a conditioning regimen for patients with relapsed multiple myeloma undergoing a second autologous blood progenitor cell transplantation.
Biol Blood Marrow Transplant
; 20(12): 1949-57, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25139216
16.
Peripheral blood progenitor cell mobilization for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 20(9): 1262-73, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24816581
17.
Pharmacoeconomics of hematopoietic stem cell mobilization: an overview of current evidence and gaps in the literature.
Biol Blood Marrow Transplant
; 19(9): 1301-9, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23685251
18.
High white blood cell concentration in the peripheral blood stem cell product can induce seizures during infusion of autologous peripheral blood stem cells.
Biol Blood Marrow Transplant
; 18(7): 1055-60, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22178402
19.
First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 18(8): 1150-63, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22510384
20.
Once daily busulfan cyclophosphamide is well tolerated and effective as a preparative regimen for allogeneic hematopoietic stem cell transplant.
J Oncol Pharm Pract
; 18(1): 17-22, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21228086